Diagnosis | Europe | International | Scans
Diagnostic CT Scan for Mesothelioma: More is Better
A new report out of the UK suggests that a thorough diagnostic CT scan for pleural mesothelioma should include images…
-
-
Biomarkers | Diagnosis | Europe | International | Prognosis
Genetics Affect Accuracy of SMRP Test for Mesothelioma
The SMRP test for mesothelioma is a tool doctors use to help diagnose asbestos cancer and plan treatment. But new… -
PD-L1 Inhibitor Nivolumab Works Well in New Mesothelioma Study
A study of the PD-L1 inhibitor nivolumab showed “safety and efficacy” in mesothelioma patients who failed with other treatments. Nivolumab… -
Immunotherapy for Pleural Mesothelioma: Biomarkers Urgently Needed
A new report says biomarkers are urgently needed to determine which patients would benefit from immunotherapy for pleural mesothelioma. Researchers… -
Immunotherapy Prompts “Remarkable Response” in Sarcomatoid Pleural Mesothelioma
Japanese doctors are reporting a remarkable response from the immunotherapy drug nivolumab in a patient with sarcomatoid pleural mesothelioma. Sarcomatoid… -
Surgery Extends Survival for Patients with Pleural Mesothelioma
Patients with pleural mesothelioma who choose to have surgery live longer than those who do not. This applies no matter… -
Can These Compounds Protect Against the Toxic Effects of Asbestos?
A recent study out of Australia suggests that compounds called zeolites might offer protection against the toxic effects of asbestos.… -
Second Line Mesothelioma Treatment Shot Down in New Study
Italian researchers say there is good news and bad news about a proposed second line mesothelioma treatment. The good news… -
Herbal Medicine for Mesothelioma Treatment: A Case Report
A group of South Korean doctors have published an account of a patient who is keeping his cancer at bay… -
Amazing Keytruda Case Study Offers Hope for Advanced Mesothelioma
Italian doctors are reporting an “impressive clinical response” in a recently published Keytruda case study. The case is encouraging news…
